01
WHAT IT IS
A research blend combining BPC-157 and TB-500, studied for tissue response, cellular repair signaling, and recovery-related pathways.
Wolverine is a co-formulated blend of BPC-157 and TB-500 — the two most-studied repair peptides — in a single vial at a 10:10 mg ratio. BPC-157 handles localized gut, tendon, and ligament repair through the body's own protective gastric pathway. TB-500 broadcasts systemic repair signaling through circulation. Combined, they cover every layer of tissue recovery from a single injection.
A quick, simple breakdown of what WOLVERINE is, why researchers study it, how it works, and what makes it unique.
A research blend combining BPC-157 and TB-500, studied for tissue response, cellular repair signaling, and recovery-related pathways.
BPC-157 is studied for localized repair signaling, while TB-500 is researched for cell migration, actin regulation, and tissue remodeling.
WOLVERINE brings together two complementary research pathways connected to soft tissue, mobility, inflammation response, and recovery models.
Designed to help visitors understand the product before exploring the full research guide.
Think of Wolverine as the complete recovery signal — local and systemic repair pathways activated together from one injection.
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide derived from a gastric protein. It accelerates tendon, ligament, and gut repair, modulates inflammation, and supports gut barrier integrity. TB-500 (Thymosin Beta-4 fragment) is a systemic signal that recruits stem cells, builds new vasculature, and reduces inflammation throughout the body.
Used alone, each addresses one half of the recovery picture. Used together — at clinically meaningful doses in a single co-formulation — they hit acute injury, chronic compensation, gut function, and systemic recovery in parallel. This is why "Wolverine" is shorthand for the stack that heals everything.
"Think of Wolverine as local repair + systemic broadcast in the same syringe — gut, tendon, ligament, vasculature, and connective tissue all signaled at once."
It doesn't replace either compound's individual mechanism. It runs both pathways simultaneously — the speed of a stack with the simplicity of a single injection.
Real recovery is multi-layered. Acute injury, chronic compensation, gut function, and systemic inflammation all degrade together — and need to be addressed together.
Tendon strains, ligament tears, and post-surgical recovery exceed the body's normal repair velocity. Native healing leaves scar tissue and incomplete restoration.
Each unresolved injury changes how you move. The compensations breed new injuries. The body needs systemic signaling to unwind the chain.
When gut integrity weakens, low-grade inflammation leaks into circulation and slows recovery everywhere else. The gut and the joints are connected.
Tendons, ligaments, and old injury sites are poorly vascularized — repair signals struggle to reach them. New vessel growth is the prerequisite for real healing.
Subcutaneous Wolverine delivers both BPC-157 and TB-500 simultaneously — engaging local and systemic repair pathways in parallel.
BPC-157 accelerates fibroblast migration, supports tendon-to-bone interface healing, restores gut barrier integrity, and modulates the nitric oxide pathway that governs vascular tone at injury sites.
TB-500 distributes through circulation — recruiting endothelial and mesenchymal stem cells to damaged tissue, building new vasculature, and lowering systemic inflammatory tone.
Acute injury, chronic compensation, gut function, and connective-tissue remodeling all advance simultaneously. One injection covers what would otherwise take two separate protocols.
Downstream effects of running local and systemic repair signals together.
Tendon, ligament, and muscular injuries recover at accelerated rates. Post-surgical recovery windows shorten visibly.
Years-old shoulder, knee, or elbow issues that local injections couldn't reach begin to genuinely heal — not just calm down.
BPC-157's gut-protective effect lowers systemic inflammation, which speeds recovery in every other tissue.
Recovery between sessions compresses. The same week of training produces less residue and allows higher quality work.
Connective tissue remodels as stem cells migrate and angiogenesis brings nutrients to long-dormant repair sites.
Both peptides modulate inflammation through distinct pathways. Combined, the systemic anti-inflammatory effect is more complete than either alone.
Surgical wounds, cuts, and soft-tissue trauma heal with less scarring and better remodeling — a hallmark of the combined repair signal.
Co-formulation eliminates the friction of running two separate protocols. The full recovery stack, in a single twice-weekly injection.
Not biomarkers. The lived experience — week by week — on a loading-and-maintenance protocol.
Loading phase. First sense of overall ease — less morning stiffness, faster recovery between training sessions. Gut function often improves first.
Chronic injury sites begin to soften. Old compensations start to unwind. Acute injuries recover at noticeably accelerated rates.
Maintenance phase. Connective tissue feels resilient. Training capacity has visibly expanded. Inflammation markers trend down on labs.
Cycle off. Repair effects continue for weeks — the structural remodeling persists well beyond the dosing window.
Exact measurements based on 10 mg vial + 2 mL bacteriostatic water.
Change any input. Every value below updates automatically from the formula. No guessing.
Units, weeks per vial, and vials per cycle — all derived from your 10 mg vial + 2 mL BAC water.
Twice-weekly loading (Mon/Thu) for 4 weeks, then once-weekly maintenance for 2 weeks. Rotate sites — abdomen, thigh, glute. Time of day flexible.
BPC-157 + TB-500 blend. Typical research window is 6 weeks (4 loading + 2 maintenance), then 4–6 weeks off.
One vial may not cover a full standard cycle. Use the standard-cycle supply option to complete the full protocol without interruption.
Body signals to expect at the standard dosing tier across the entire cycle. Individual response varies — this is a realistic reference, not a guarantee.
Wolverine covers local and systemic repair. Paired with the right co-signals, recovery becomes the foundation everything else compounds on.
Wolverine covers cellular repair. GHK-Cu governs the matrix those cells build. Higher-quality rebuild.
Repair + growth in one window. Wolverine rebuilds; IGF-1 LR3 pushes the new tissue to full contractile capacity.
Repair is energetically expensive. NAD+ ensures the mitochondria powering the rebuild aren't running on empty.
Wolverine is a co-formulated blend of BPC-157 (10 mg) and TB-500 (10 mg). BPC-157 drives local tissue and gut repair; TB-500 broadcasts systemic repair signaling through circulation. Together they cover acute injury, chronic compensation, gut function, and systemic inflammation in a single injection.
Initial recovery improvements at 7–14 days. Chronic injury improvements at 3–4 weeks. Structural connective tissue remodeling continues for weeks beyond the cycle.
Loading: 0.5 mL subcutaneously twice weekly (2.5 mg of each peptide per injection) for 4 weeks. Maintenance: 0.5 mL once weekly for 2 weeks. Total cycle 6 weeks, then 4–6 weeks off.
Both peptides are generally well tolerated. Possible: brief injection-site irritation, mild fatigue during loading, transient appetite or digestion changes. Theoretical caution with active malignancy due to stem-cell recruitment by TB-500 — avoid in that context. Consult a clinician.
Every batch of our Wolverine blend is independently third-party tested for purity (>99%), peptide identity via HPLC and mass spectrometry, ratio accuracy, and endotoxin levels. A Certificate of Analysis is available for the exact lot you receive. We ship from a temperature-controlled facility in San Diego.
The shoulder that never quite healed becomes the hip that's always tight becomes the knee that catches. Wolverine activates both repair signals at once — local and systemic — so the chain can finally unwind.
Research-grade Wolverine blend, BPC-157 10 mg + TB-500 10 mg per vial. Third-party tested. The complete recovery stack in a single injection.
Explore WolverineSource WOLVERINE from Blueprint Peak Performance — third-party tested for >99% purity, cold-chain handled, shipped from San Diego. Educational research use only.
Blueprint Research Guide is editorial. The link above sources research-grade compounds from Blueprint Peak Performance — an independent supplier. For educational purposes only. Research use only — not for human consumption, treatment, or diagnosis.